Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2022-09-27 00:00:00 ET · period of report 2022-09-25 · accession 0001628280-22-025566 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-27 | 2022-09-25+ | MYGN | Lambert Nicole | COO | F - Tax | $18.46 | -3,592 | 244.3K | -1% | -$66.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-26 | F | D | 2,950 | $18.41 | 241,375 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-25 | F | D | 642 | $18.69 | 244,325 | D | — | — |